Evidence map›Paper›PMID 19470446›Full record

ArticleMolecular & cellular proteomics : MCP2009

Delineation of a carcinogenic Helicobacter pylori proteome.

Aime T Franco, David B Friedman, Toni A Nagy, Judith Romero-Gallo, Uma Krishna, Amy Kendall, Dawn A Israel, Nicole Tegtmeyer, M Kay Washington, Richard M Peek

Open access · hybridAbstract read
In one paragraph

Article in Molecular & cellular proteomics : MCP, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
6.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 46 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Protein signature characterizingInfectious agents and cancer · 2017
    Article
  7. Gene polymorphisms of pathogenicWorld journal of gastroenterology · 2016
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. The Helicobacter pylori cag Pathogenicity Island.Methods in molecular biology (Clifton, N.J.) · 2012
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Aime T FrancoDivision of Gastroenterology, Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee 37232-2279, USA.
David B Friedman
Toni A Nagy
Judith Romero-Gallo
Uma Krishna
Amy Kendall
Dawn A Israel
Nicole Tegtmeyer
M Kay Washington
Richard M Peek
Vanderbilt University · USUniversity College Dublin · IE

Funding

Translational Analysis CoreP30DK058404 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI RICHARD M. PEEK · 2002 to 2026
$29.9M
Role of Iron and B-Catenin Activation in Gastric CarcinogenesisP01CA116087 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI RICHARD M. PEEK · 2009 to 2026
$27.5M
H.Pylori Relationship to Digestive Diseases and CancerR01CA077955 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI RICHARD M. PEEK · 2003 to 2026
$9.7M
Helicobacter Pylori and Gastrointestinal BiologyR01DK058587 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI PEEK, RICHARD M. · 2001 to 2024
$7.8M
H PYLORI RELATIONSHIP TO DIGESTIVE DISEASES AND CANCERR29CA077955 · NCI · VANDERBILT UNIVERSITY · PI PEEK, RICHARD M · 1997 to 2001
$294k
NCI NIH HHS CA116087NCI NIH HHS CA77955NCI NIH HHS P01 CA116087NCI NIH HHS R01 CA077955NCI NIH HHS R29 CA077955NIDDK NIH HHS DK058404NIDDK NIH HHS DK58587NIDDK NIH HHS P30 DK058404NIDDK NIH HHS R01 DK058587
6 · The paper itself

Abstract

Helicobacter pylori is the strongest known risk factor for gastric adenocarcinoma, yet only a fraction of infected persons ever develop cancer. The extensive genetic diversity inherent to this pathogen has precluded comprehensive analyses of constituents that mediate carcinogenesis. We previously reported that in vivo adaptation of a non-carcinogenic H. pylori strain endowed the output derivative with the ability to induce adenocarcinoma, providing a unique opportunity to identify proteins selectively expressed by an oncogenic H. pylori strain. Using a global proteomics DIGE/MS approach, a novel missense mutation of the flagellar protein FlaA was identified that affects structure and function of this virulence-related organelle. Among 25 additional differentially abundant proteins, this approach also identified new proteins previously unassociated with gastric cancer, generating a profile of H. pylori proteins to use in vaccine development and for screening persons infected with strains most likely to induce severe disease.

Indexed as

AnimalsBacterial ProteinsBlotting, WesternCell LineElectrophoresis, Gel, Two-DimensionalFlagellinGerbillinaeHelicobacter InfectionsHelicobacter pyloriHumansMaleMicroscopy, Electron, TransmissionMutation, MissenseProteomeProteomicsSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationBacterial ProteinsflaA protein, bacteriaFlagellinProteome

Identifiers

PMID19470446
PMCPMC2722763
OpenAlexW2155701046

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.